folder Filed in Funding daily
Biotech company LYNK Pharmaceuticals raised $50 million in Series B round
By Tsani Gramatikova access_time 1 min read
access_time 1 min read
access_time 1 min read
access_time 1 min read
access_time 1 min read
access_time 1 min read
access_time 1 min read
access_time 1 min read
access_time 1 min read
access_time 1 min read
access_time 1 min read
access_time 13 min read
access_time 3 min read
more_horiz Load more